Crossref journal-article
Elsevier BV
Molecular Therapy (78)
Bibliography

Pulicherla, N., Shen, S., Yadav, S., Debbink, K., Govindasamy, L., Agbandje-McKenna, M., & Asokan, A. (2011). Engineering Liver-detargeted AAV9 Vectors for Cardiac and Musculoskeletal Gene Transfer. Molecular Therapy, 19(6), 1070–1078.

Authors 7
  1. Nagesh Pulicherla (first)
  2. Shen Shen (additional)
  3. Swati Yadav (additional)
  4. Kari Debbink (additional)
  5. Lakshmanan Govindasamy (additional)
  6. Mavis Agbandje-McKenna (additional)
  7. Aravind Asokan (additional)
References 46 Referenced 195
  1. {'key': '10.1038/mt.2011.22_bib1', 'first-page': '105', 'article-title': 'Two decades of clinical gene therapy–success is finally mounting', 'volume': '9', 'author': 'Herzog', 'year': '2010', 'journal-title': 'Discov Med'} / Discov Med / Two decades of clinical gene therapy–success is finally mounting by Herzog (2010)
  2. 10.2174/156652310793180706 / Curr Gene Ther / AAV's anatomy: roadmap for optimizing vectors for translational success by Mitchell (2010)
  3. 10.1038/mt.2008.76 / Mol Ther / Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection by Zincarelli (2008)
  4. 10.1016/j.ymthe.2006.03.014 / Mol Ther / Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8 by Inagaki (2006)
  5. 10.1161/01.RES.0000237661.18885.f6 / Circ Res / Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo by Pacak (2006)
  6. 10.1073/pnas.0813207106 / Proc Natl Acad Sci USA / A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection by Yang (2009)
  7. 10.1038/nbt.1515 / Nat Biotechnol / Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes by Foust (2009)
  8. 10.1038/mt.2010.94 / Mol Ther / Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs by Kornegay (2010)
  9. 10.1517/14712590903321462 / Expert Opin Biol Ther / Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure by Lipskaia (2010)
  10. 10.1038/gt.2008.71 / Gene Ther / AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects by Hasbrouck (2008)
  11. 10.1073/pnas.0904514106 / Proc Natl Acad Sci USA / Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy by Brantly (2009)
  12. 10.1038/mt.2010.51 / Mol Ther / Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs by Halbert (2010)
  13. 10.1038/sj.mt.6300027 / Mol Ther / Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle by Salva (2007)
  14. 10.1038/gt.2008.104 / Gene Ther / Construction and analysis of compact muscle-specific promoters for AAV vectors by Wang (2008)
  15. 10.1038/nrg2628 / Nat Rev Genet / Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications by Brown (2009)
  16. 10.1371/journal.pone.0005122 / PLoS ONE / Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries by Michelfelder (2009)
  17. 10.1038/gt.2010.44 / Gene Ther / Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library by Ying (2010)
  18. 10.1073/pnas.0813365106 / Proc Natl Acad Sci USA / Directed evolution of adeno-associated virus to an infectious respiratory virus by Excoffon (2009)
  19. 10.1038/mt.2009.184 / Mol Ther / Molecular evolution of adeno-associated virus for enhanced glial gene delivery by Koerber (2009)
  20. 10.1128/JVI.77.12.6995-7006.2003 / J Virol / Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding by Opie (2003)
  21. 10.1128/JVI.77.20.11072-11081.2003 / J Virol / Identification of a heparin-binding motif on adeno-associated virus type 2 capsids by Kern (2003)
  22. 10.1128/JVI.00843-06 / J Virol / Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry by Asokan (2006)
  23. 10.1073/pnas.162250899 / Proc Natl Acad Sci USA / The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy by Xie (2002)
  24. 10.1128/JVI.01536-06 / J Virol / Structurally mapping the diverse phenotype of adeno-associated virus serotype 4 by Govindasamy (2006)
  25. 10.1128/JVI.01288-06 / J Virol / Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes by Wu (2006)
  26. 10.1128/JVI.01304-07 / J Virol / Structure of adeno-associated virus serotype 8, a gene therapy vector by Nam (2007)
  27. 10.1038/nbt.1599 / Nat Biotechnol / Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle by Asokan (2010)
  28. 10.1089/hum.2008.123 / Hum Gene Ther / Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat by Bish (2008)
  29. 10.1016/j.jsb.2008.12.002 / J Struct Biol / Heparin binding induces conformational changes in Adeno-associated virus serotype 2 by Levy (2009)
  30. 10.1016/j.virol.2010.03.027 / Virology / The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion by Lerch (2010)
  31. 10.1006/viro.2001.1254 / Virology / Uptake and processing of modified bacteriophage M13 in mice: implications for phage display by Molenaar (2002)
  32. 10.1021/ja075937f / J Am Chem Soc / Plasma clearance of bacteriophage Qbeta particles as a function of surface charge by Prasuhn (2008)
  33. 10.1016/S0065-2660(09)67002-4 / Adv Genet / Adeno-associated viral vectors and their redirection to cell-type specific receptors by Michelfelder (2009)
  34. 10.1128/JVI.80.2.821-834.2006 / J Virol / Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization by Lochrie (2006)
  35. 10.1128/JVI.00878-06 / J Virol / The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9 by Akache (2006)
  36. 10.1128/JVI.79.17.11280-11290.2005 / J Virol / Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor by Rubio (2005)
  37. 10.1074/jbc.M604421200 / J Biol Chem / Identification of the sialic acid structures recognized by minute virus of mice and the role of binding affinity in virulence adaptation by Nam (2006)
  38. 10.1073/pnas.0711757105 / Proc Natl Acad Sci USA / Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo by Kalyuzhniy (2008)
  39. 10.1162/1535350041464847 / Mol Imaging / Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter by Boecker (2004)
  40. {'key': '10.1038/mt.2011.22_bib40', 'article-title': 'Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver', 'author': 'Qiao', 'year': '2010', 'journal-title': 'Gene Ther'} / Gene Ther / Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver by Qiao (2010)
  41. 10.1038/gt.2010.141 / Gene Ther / microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors by Geisler (2011)
  42. 10.1128/JVI.78.12.6381-6388.2004 / J Virol / Clades of Adeno-associated viruses are widely disseminated in human tissues by Gao (2004)
  43. 10.1093/bioinformatics/bti770 / Bioinformatics / The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling by Arnold (2006)
  44. 10.1093/nar/gkn840 / Nucleic Acids Res / VIPERdb2: an enhanced and web API enabled relational database for structural virology by Carrillo-Tripp (2009)
  45. 10.1016/j.jsb.2006.10.013 / J Struct Biol / Interpretation of electron density with stereographic roadmap projections by Xiao (2007)
  46. 10.1038/nprot.2006.207 / Nat Protoc / Production and characterization of adeno-associated viral vectors by Grieger (2006)
Dates
Type When
Created 14 years, 6 months ago (March 2, 2011, 8:47 p.m.)
Deposited 6 years, 2 months ago (June 8, 2019, 7:33 p.m.)
Indexed 5 days, 1 hour ago (Aug. 31, 2025, 6:13 a.m.)
Issued 14 years, 3 months ago (June 1, 2011)
Published 14 years, 3 months ago (June 1, 2011)
Published Print 14 years, 3 months ago (June 1, 2011)
Funders 0

None

@article{Pulicherla_2011, title={Engineering Liver-detargeted AAV9 Vectors for Cardiac and Musculoskeletal Gene Transfer}, volume={19}, ISSN={1525-0016}, url={http://dx.doi.org/10.1038/mt.2011.22}, DOI={10.1038/mt.2011.22}, number={6}, journal={Molecular Therapy}, publisher={Elsevier BV}, author={Pulicherla, Nagesh and Shen, Shen and Yadav, Swati and Debbink, Kari and Govindasamy, Lakshmanan and Agbandje-McKenna, Mavis and Asokan, Aravind}, year={2011}, month=jun, pages={1070–1078} }